Echocardiographic Findings in HIV-Infected Patients

  • S. Ederhy
  • C. Meuleman
  • N. Haddour
  • G. Dufaitre
  • F. Boccara
  • A. Cohen


Echocardiography is an important imaging technique providing real-time imaging that can be performed at the bedside and easily repeated as needed (Table 1). Before the era of highly active anti-retroviral therapy (HAART), cardiac complications in HIV included pericardial effusion, dilated cardiomyopathy, myocarditis, endocarditis, pulmonary hypertension, cardiac neoplasm, coronary artery disease and drug-related cardiotoxicity [1, 2]. Cardiac abnormalities, although usually clinically silent, can be detected in necropsy series in the majority of infected HIV patients (40–60%) [3].


Pulmonary Arterial Hypertension Dilate Cardiomyopathy Infective Endocarditis Pericardial Effusion Cardiac Tamponade 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Barbaro G (2002) Cardiovascular manifestations of HIV infection. Circulation 106:1420–5CrossRefPubMedGoogle Scholar
  2. 2.
    Fisher SD, Lipshultz SE (2001) Epidemiology of cardiovascular involvement in HIV disease and AIDS. Ann NY Acad Sci 946:13–22PubMedCrossRefGoogle Scholar
  3. 3.
    Barbaro G (2003) Evolution of the involvement of the cardiovascular system in HIV infection. Adv Cardiol 40:15–22CrossRefPubMedGoogle Scholar
  4. 4.
    Barbarini G, Barbaro G (2003) Incidence of the involvement of the cardiovascular system in HIV infection. AIDS 17:S46–50Google Scholar
  5. 5.
    Reuter H, Burgess LJ, Doubell AF (2005) Epidemiology of pericardial effusions at a large academic hospital in South Africa. Epidemiol Infect 133:393–399CrossRefPubMedGoogle Scholar
  6. 6.
    Heidenreich PA, Eisenberg MJ, Kee LL et al (1995) Pericardial effusion in AIDS: incidence and survival. Circulation 92:3229–3234PubMedGoogle Scholar
  7. 7.
    Chen Y, Brennessel D, Walters J et al (1999) Immunodeficiency virus-associated pericardial effusion: report of 40 cases and review of the literature. Am Heart J 137:516–521CrossRefPubMedGoogle Scholar
  8. 8.
    Pugliese A, Isnardi D, Saini A et al (2000) Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement. J Infect 40:282–284CrossRefPubMedGoogle Scholar
  9. 9.
    Roy CL, Minor MA, Brookhart MA, Choudhry NK (2007) Does this patient with a pericardial effusion have cardiac tamponade? JAMA 297:1810–1818CrossRefPubMedGoogle Scholar
  10. 10.
    Gowda RM, Khan IA, Sacchi TJ, Vasavada BC (2003) Cardiac tamponade in acquired immunodeficiency syndrome. Int J Cardiol 88:313–314CrossRefPubMedGoogle Scholar
  11. 11.
    Iacobellis G, Pellicelli AM, Sharma AM et al (2007) Relation of subepicardial adipose tissue to carotid intima-media thickness in patients with human immunodeficiency virus. Am J Cardiol 99:1470–1472CrossRefPubMedGoogle Scholar
  12. 12.
    Pinamonti B, Alberti E, Cigalotto A et al (1988) Echocardiographic findings in myocarditis. Am J Cardiol 62:285–289CrossRefPubMedGoogle Scholar
  13. 13.
    Camerini F, Bussani R, Lenarda D et al (1991) Clinical aspects and haemodynamics in the followup of dilated cardiomyopathy and myocarditis. Eur Heart J 12(Suppl D):193–196PubMedGoogle Scholar
  14. 14.
    Hiramitsu S, Morimoto S, Kato S et al (2001) Transient ventricular wall thickening in acute myocarditis: a serial echocardiographic and histopathologic study. Jpn Circ 65:863–866CrossRefGoogle Scholar
  15. 15.
    Lieback E, Hardouin I, Meyer R et al (1996) Clinical value of echocardiographic tissue characterization in the diagnosis of myocarditis. Eur Heart J 17:135–142PubMedGoogle Scholar
  16. 16.
    Felker GM, Boehmer JP, Hruban RH et al (2000) Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol 36:227–232CrossRefPubMedGoogle Scholar
  17. 17.
    Mendes LA, Picard MH, Dec GW et al (1999) Ventricular remodeling in active myocarditis: myocarditis treatment trial. Am Heart J 138:303–308CrossRefPubMedGoogle Scholar
  18. 18.
    Thuny F, Avierinos JF, Jop B et al (2006) Images in cardiovascular medicine: massive biventricular thrombosis as a consequence of myocarditis: findings from 2-dimensional and real-time 3-dimensional echocardiography. Circulation 113:e932–933CrossRefPubMedGoogle Scholar
  19. 19.
    Mendes LA, Dec GW, Picard MH et al (1994) Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis. Am Heart J 128:301–307CrossRefPubMedGoogle Scholar
  20. 20.
    Swedberg K, Cleland J, Dargie H et al (2005) Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26:1115–1140CrossRefPubMedGoogle Scholar
  21. 21.
    Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G (1998) Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIVpositive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS. N Engl J Med 339:1093–1099CrossRefPubMedGoogle Scholar
  22. 22.
    Cardoso JS, Moura B, Martins L et al (1998) Left ventricular dysfunction in human immunodeficiency virus (HIV) infected patients. Int J Cardiol 63:37–45CrossRefPubMedGoogle Scholar
  23. 23.
    Longo-Mbenza B, Seghers KV, Phuati M et al (1998) Heart involvement and HIV infection in African patients: determinants of survival. Int J Cardiol 64:63–73CrossRefPubMedGoogle Scholar
  24. 24.
    Twagirumukiza M, Nkeramihigo E, Seminega B et al (2007) Prevalence of dilated cardiomyopathy in HIV-infected African patients not receiving HAART: a multicenter, observational, prospective, cohort study in Rwanda. Curr HIV Res 5:129–137CrossRefPubMedGoogle Scholar
  25. 25.
    Brown DL, Sather S, Cheitlin MD (1993) Reversible cardiac dysfunction associated with foscarnet therapy for cytomegalovirus esophagitis in an AIDS patient. Am Heart J 125:1439–1441CrossRefPubMedGoogle Scholar
  26. 26.
    Galia N, Torbicki A, Barst R et al (2004) Guidelines on diagnosis and treatment of pulmonary arterial hypertension: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 25:2243–2278CrossRefGoogle Scholar
  27. 27.
    Opravil M, Pechere M, Speich R et al (1997) HIV-associated primary pulmonary hypertension: a case control study. Swiss HIV Cohort Study. Am J Respir Crit Care Med 155:990–995PubMedGoogle Scholar
  28. 28.
    Mesa RA, Edell ES, Dunn WF, Edwards WD (1988) Human immunodeficiency virus infection and pulmonary hypertension: two new cases and a review of 86 reported cases. Mayo Clin Proc 73:37–45CrossRefGoogle Scholar
  29. 29.
    Petitpretz P, Brenot F, Azarian R et al (1994) Pulmonary hypertension in patients with human immunodeficiency virus infection: comparison with primary pulmonary hypertension. Circulation 89:2722–2727PubMedGoogle Scholar
  30. 30.
    Ehrenreich H, Rieckmann P, Sinowatz F et al (1993) Potent stimulation of monocytic endothelin-1 production by HIV-1 glycoprotein 120. J Immunol 150:4601–4609PubMedGoogle Scholar
  31. 31.
    Humbert M, Monti G, Fartoukh M et al (1998) Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients. Eur Respir J 11:554–559PubMedGoogle Scholar
  32. 32.
    Mehta NJ, Khan IA, Mehta RN, Sepkowitz DA (2000) HIV-related pulmonary hypertension: analytic review of 131 cases. Chest 118:1133–1141CrossRefPubMedGoogle Scholar
  33. 33.
    Zuber JP, Calmy A, Evison JM et al; Swiss HIV Cohort Study Group (2004) Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy. Clin Infect Dis 38:1178–1185CrossRefPubMedGoogle Scholar
  34. 34.
    Lang RM, Bierig M, Devereux RB et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification. J Am Soc Echocardiogr 18:1440–1463CrossRefPubMedGoogle Scholar
  35. 35.
    Martinez-Garcia T, Sobrino JM, Pujol E et al (2000) Ventricular mass and diastolic function in patients infected by the humanimmuno deficiency virus. Heart 84:620–624CrossRefPubMedGoogle Scholar
  36. 36.
    Coudray N, de Zuttere D, Force G et al (1995) Ventricular diastolic function in asymptomatic and symptomatic human immunodeficiency virus carriers: an echocardiographic study. Eur Heart J 16:61–67PubMedGoogle Scholar
  37. 37.
    Samaan SA, Foster A, Raizada V et al (1995) Myocardial atrophy in acquired immunodeficiency syndrome: associated wasting. Am Heart J 130:823–827CrossRefPubMedGoogle Scholar
  38. 38.
    Meng Q, Lima JA, Lai H, Vlahov D et al (2002) HIV protease inhibitors is associated with left ventricular morphologic changes and diastolic dysfunction. J Acquir Immune Defic Syndr 30:306–310PubMedGoogle Scholar
  39. 39.
    Losa JE, Miro JM, Del Rio A et al (2003) Endocarditis not related to intravenous drug abuse in HIV-1-infected patients: report of eight cases and review of the literature. Clin Microbiol Infect 9:45–54CrossRefPubMedGoogle Scholar
  40. 40.
    De Rosa FG, Cicalini S, Canta F et al (2007) Infective endocarditis in intravenous drug users from Italy: the increasing importance in HIVinfected patients. Infection 35:154–160CrossRefPubMedGoogle Scholar
  41. 41.
    Gebo KA, Burkey MD, Lucas GM et al (2006) Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort. J Acquir Immune Defic Syndr 43:426–432CrossRefPubMedGoogle Scholar
  42. 42.
    Valencia E, Miro J (2004) Endocarditis in the setting of HIV infection. AIDS Rev 6:97–106PubMedGoogle Scholar
  43. 43.
    Horstkotte D, Follath F, Gutschik E et al (2004) Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary: the task force on infective endocarditis of the European society of cardiology. Eur Heart J 25:267–276CrossRefPubMedGoogle Scholar
  44. 44.
    Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA; HIV/AIDS Cancer Match Study (2007) AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst 99:962–972CrossRefPubMedGoogle Scholar
  45. 45.
    Khan NU, Ahmed S, Wagner P et al (2004) Cardiac involvement in non-Hodgkin’s lymphoma: with and without HIV infection. Int J Cardiovasc Imaging 20:477–481CrossRefPubMedGoogle Scholar
  46. 46.
    Iwahashi N, Nakatani S, Kakuchi H et al (2005) Cardiac tumor as an initial manifestation of acquired immunodeficiency syndrome. Circ J 69:243–245CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2009

Authors and Affiliations

  • S. Ederhy
    • 1
  • C. Meuleman
    • 1
  • N. Haddour
    • 1
  • G. Dufaitre
    • 1
  • F. Boccara
    • 1
  • A. Cohen
    • 1
  1. 1.Département de CardiologieAssistance Publique-Hôpitaux de Paris et Université Pierre et Marie Curie, Centre Hospitalier Universitaire Saint-AntoineParisFrance

Personalised recommendations